CN113528478A - Method for efficiently producing transglutaminase and special engineering bacteria thereof - Google Patents

Method for efficiently producing transglutaminase and special engineering bacteria thereof Download PDF

Info

Publication number
CN113528478A
CN113528478A CN202010284432.5A CN202010284432A CN113528478A CN 113528478 A CN113528478 A CN 113528478A CN 202010284432 A CN202010284432 A CN 202010284432A CN 113528478 A CN113528478 A CN 113528478A
Authority
CN
China
Prior art keywords
mtg
protein
pro
sequence
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010284432.5A
Other languages
Chinese (zh)
Other versions
CN113528478B (en
Inventor
董志扬
张楠
张山
何永志
张岩峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Microbiology of CAS
Original Assignee
Institute of Microbiology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Microbiology of CAS filed Critical Institute of Microbiology of CAS
Priority to CN202010284432.5A priority Critical patent/CN113528478B/en
Publication of CN113528478A publication Critical patent/CN113528478A/en
Application granted granted Critical
Publication of CN113528478B publication Critical patent/CN113528478B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/104Aminoacyltransferases (2.3.2)
    • C12N9/1044Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/77Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y203/00Acyltransferases (2.3)
    • C12Y203/02Aminoacyltransferases (2.3.2)
    • C12Y203/02013Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention discloses a method for efficiently producing transglutaminase and a special engineering bacterium thereof. The invention provides a protein which is shown as a sequence 2 in a sequence table. The invention also relates to recombinant microorganisms which are obtained by introducing DNA molecules expressing said proteins into C.glutamicum. The recombinant microorganism can be used for preparing transglutaminase. The MTG derived from streptomyces mobaraensis is expressed under a T7 promoter, intein ssp-dnaB is inserted between a pro region and a mature region of the MTG to successfully realize the high-efficiency expression of the MTG in corynebacterium glutamicum, and after the thalli obtained by fermentation are subjected to ultrasonic disruption, the MTG with biological activity can be obtained without protease treatment or other condition changes. The invention can be used for preparing transglutaminase, is further applied to the fields of tissue engineering, textile and leather processing and the like, and has application and popularization values.

Description

Method for efficiently producing transglutaminase and special engineering bacteria thereof
Technical Field
The invention belongs to the technical field of biology, and particularly relates to a method for efficiently producing transglutaminase and a special engineering bacterium thereof.
Background
Transglutaminase (Transglutaminase, EC 2.3.2.13, TGase) belongs to the transferase family and catalyzes the acyl transfer from the gamma-carboxamide group (donor) of a glutamine residue to various primary amines (acyl acceptor). Currently, TGase has been used in the food processing field for more than 10 years and is Generally Recognized As Safe (GRAS) by the united states Food and Drug Administration (FDA). TGase can improve the properties of proteins by intramolecular and intermolecular cross-linking of proteins. Therefore, the enzyme shows wider application value in the fields of tissue engineering, textile and leather processing and the like.
TGase is widely available in animals and plants, but the yield is low, and the cost of separation and purification is high, so that the TGase is far from meeting the requirements of people. In 1989, microorganism-derived TGase (Microbial TGase, MTG) was first discovered, and MTG had non-Ca compared with other TGase sources2+Dependence, high temperature, high pH stability and the like. In addition, the microbial method for producing MTG has the advantages of short production period, high yield, low cost, easy industrial production and the like. Therefore, there is a tendency to use microbiological methods for the large-scale production of MTG.
MTG is usually secreted extracellularly in the form of an inactive proenzyme (pro-MTG), and the pro-enzyme region (pro region) is cleaved off by proteolytic cleavage to form an active mature MTG. The existence of pro region plays an important role in the formation of correct spatial structure and secretion of MTG.
An intein is a protein that enables protein splicing through nucleophilic substitution between amino acids without the involvement of other cofactors. Due to its unique mechanism of action, it is now widely used in biotechnology, biomedicine and protein chemistry. dnaB is a DNA helicase gene derived from Synechocystis sp code, and 106 amino acids at C-terminal and 48 amino acids at N-terminal form the minimum action unit of intein after optimization and modification. The C-terminal cleavage of the optimized intein ssp-dnaB is pH dependent.
At present, more and more expression systems are used for expressing MTG, but the problems of low expression level, secondary treatment of protease in the later period and the like exist. Some researches successfully realize the expression of MTG in escherichia coli and bacillus subtilis by using intein, but still need secondary treatment with pH or temperature change to realize the shearing of pro region, thereby greatly increasing the industrial production cost and time cost.
Disclosure of Invention
The invention aims to provide a method for efficiently producing transglutaminase and a special engineering bacterium thereof.
The invention provides a protein (protein A), which is (a1) or (a2) as follows:
(a1) protein shown by 1-532 th amino acid residues in a sequence 2 in a sequence table;
(a2) a protein shown in a sequence 2 in a sequence table.
Nucleic acid molecules which code for said protein A also belong to the scope of protection of the present invention.
DNA molecules encoding said protein A also belong to the scope of protection of the present invention.
The DNA molecule is specifically any one of the following (b1) to (b 6):
(b1) the coding region is shown as the nucleotide 6389-7981 of the sequence 1 in the sequence table;
(b2) the coding region is shown as the nucleotide 6386-7981 of the sequence 1 in the sequence table;
(b3) the coding region is shown as the nucleotide 6389-7999 of the sequence 1 in the sequence table;
(b4) the coding region is shown as the nucleotide 6386-7999 of the sequence 1 in the sequence table;
(b5) the coding region is shown as 6389 and 8002 nucleotides in the sequence 1 of the sequence table;
(b6) the coding region is shown as the DNA molecule at the 6386-8002 site nucleotide of the sequence 1 in the sequence table.
Expression cassettes, recombinant vectors or recombinant microorganisms having the DNA molecules are within the scope of the invention.
The recombinant vector is specifically (c1) or (c2) as follows:
(c1) a recombinant vector with 6304-8002 nucleotides of sequence 1 in the sequence table;
(c2) the recombinant vector is shown as a sequence 1 in a sequence table.
The recombinant microorganism is obtained by introducing the recombinant vector into Corynebacterium glutamicum (Corynebacterium glutamicum).
The Corynebacterium glutamicum may be Corynebacterium glutamicum C.glutamicum T7.
Corynebacterium glutamicum C.glutamicum T7 is a recombinant strain obtained by introducing T7-Plac into Corynebacterium glutamicum ATCC 13032. Corynebacterium glutamicum C.glutamicum T7 is a recombinant strain obtained by integrating T7-Plac into the genomic DNA of Corynebacterium glutamicum ATCC 13032. T7-Plac is a DNA molecule consisting of 537-4951 th nucleotides of sequence 4 of the sequence table.
The difference between corynebacterium glutamicum c.glutamicum T7 compared to corynebacterium glutamicum ATCC13032 was only: the double-stranded DNA molecule shown in the sequence 5 in the sequence table in the genomic DNA of Corynebacterium glutamicum ATCC13032 was replaced by a double-stranded DNA molecule shown in the 17 th to 5461 th nucleotides of the sequence table in the sequence table.
The invention also protects the application of the protein A or the nucleic acid molecule or the DNA molecule or the expression cassette or the recombinant vector or the recombinant microorganism in the preparation of transglutaminase.
The invention also provides a method for preparing transglutaminase, which comprises the following steps: culturing the recombinant microorganism.
The process for preparing transglutaminase further comprises the steps of: after the completion of the culture, the cells were collected and disrupted.
The process for preparing transglutaminase further comprises the steps of: and collecting supernatant after the thalli are crushed.
The process for preparing transglutaminase further comprises the steps of: collecting the supernatant, and collecting the supernatant with His by nickel column affinity chromatography6A tagged protein.
The process for preparing transglutaminase further comprises the steps of: after completion of the nickel column affinity chromatography, desalting and replacing the solvent system. The solvent system may be specifically Tris-HCl buffer solution with pH8.0 and 50 mM.
The method for culturing the recombinant microorganism specifically comprises the following steps:
(1) culturing the recombinant microorganism to OD using a liquid medium600nmThe value is 1;
(2) after completion of step (1), IPTG is added to the culture system so that the concentration thereof in the system becomes 0.1 to 1mM, and then the culture is carried out.
The culture conditions of step (1) may be: shaking and culturing at 30 deg.C and 200 r/min.
The culture conditions of step (2) may be: culturing at 16-30 deg.C.
The culture conditions of step (2) may be: culturing at 25 deg.C under shaking at 200r/min for 48 h.
The method for culturing the recombinant microorganism specifically may be: 1 volume part of the seed solution is inoculated into 10 volume parts of the liquid culture medium and fermented for 48 hours. During the fermentation process, the temperature is controlled at 25 ℃, and the pH value is controlled at about 7.0 by feeding ammonia water. During the fermentation process, when the system OD600nmWhen the value reached 8 to 10, IPTG was added so that its concentration in the system became 0.1 to 1 mM. During the fermentation, the glucose concentration of the system was monitored and maintained at 4-6g/L by feeding 50g/100ml of an aqueous glucose solution.
The concentration of IPTG in the system may be in particular 0.5 mM.
The liquid culture medium can be specifically a fermentation culture medium containing 17 mu g/mL chloramphenicol.
The preparation method of the seed liquid comprises the following steps: the strain CG-pXMJ19-pro-ssp-dnaB155MAnd (3) inoculating the MTG single colony to a test tube filled with 5mL of liquid BHI culture medium containing 17 mu g/mL of chloramphenicol, and carrying out shake culture at 30 ℃ at 200r/min for 12h to obtain the seed solution.
The invention also provides a protein (protein B) which sequentially consists of the following components from the N end to the C end: the pro region of MTG, the ssp-dnaB intein, the mature region of amino acid residue M, MTG.
MTG is transglutaminase derived from microorganisms.
The MTG is specifically MTG derived from Streptomyces mobaraensis (Streptomyces mobaraensis).
The pro region of MTG is shown as amino acid residues from 2 nd to 46 th in the sequence 2 of the sequence table, or is shown as amino acid residues from 1 st to 46 th in the sequence 2 of the sequence table.
The ssp-dnaB intein is shown as amino acid residues at 47 th to 200 th positions in a sequence 2 of a sequence table.
The mature region of MTG is shown as the amino acid residue at position 202-532 of the sequence 2 in the sequence table.
Nucleic acid molecules which code for the protein B also belong to the scope of protection of the invention.
The DNA molecule for coding the protein B also belongs to the protection scope of the invention.
Expression cassettes, recombinant vectors or recombinant microorganisms having the DNA molecules are within the scope of the invention.
The recombinant microorganism can be used for producing transglutaminase.
The recombinant microorganism is obtained by introducing the recombinant vector into corynebacterium glutamicum.
The invention also provides a protein (protein C), which sequentially comprises the following segments from the N end to the C end: protein B and protein label. The protein tag can be His6And (4) a label.
Nucleic acid molecules encoding the protein C also fall within the scope of the invention.
The DNA molecule for coding the protein C also belongs to the protection scope of the invention.
Expression cassettes, recombinant vectors or recombinant microorganisms having the DNA molecules are within the scope of the invention.
The recombinant microorganism is obtained by introducing the recombinant vector into corynebacterium glutamicum.
The recombinant microorganism can be used for producing transglutaminase.
The MTG derived from Streptomyces mobaraensis is expressed under a T7 promoter, intein ssp-dnaB is inserted between a pro region and a mature region of the MTG to successfully realize the high-efficiency expression of the MTG in Corynebacterium glutamicum, and after the thalli obtained by fermentation are subjected to ultrasonic disruption, protease treatment or other condition change is not needed, so that the MTG with biological activity can be obtained.
The recombinant microorganism obtained by the invention can reach 14U/mL by adopting a shake flask to ferment for 48h at 25 ℃, and can reach 49U/mL by adopting a fermentation tank to ferment for 48h at 25 ℃ in a high-density manner.
The invention can be used for preparing transglutaminase, is further applied to the fields of tissue engineering, textile and leather processing and the like, and has application and popularization values.
Drawings
FIG. 1 is the protein electrophoretogram in step five of example 2.
FIG. 2 is a comparison of enzyme activities in step seven of example 2.
FIG. 3 is a graph showing the results of the optimum reaction temperature in example 4.
FIG. 4 is a graph showing the results of temperature stability in example 4.
FIG. 5 is a graph showing the results of optimum pH in example 4.
FIG. 6 is a graph showing the results of pH stability in example 4.
Detailed Description
The following examples are given to facilitate a better understanding of the invention, but do not limit the invention. The experimental procedures in the following examples are conventional unless otherwise specified. The test materials used in the following examples were purchased from a conventional biochemical reagent store unless otherwise specified. The quantitative tests in the following examples, all set up three replicates and the results averaged. L-glutamic acid- γ -monohydroxyhydroxamic acid: sigma, product number G2253. N-benzyloxycarbonyl-L-glutamylglycine (N-CBZ-Gln-Gly): sigma, product number C6154. Corynebacterium glutamicum ATCC13032 is the Corynebacterium glutamicum of ATCC 13032.
Brain heart leachate broth medium (liquid BHI medium): 37g of the composite dry powder is dissolved in water and the volume is up to 1L. Compounding dry powder: beijing Runzukang Biotech, Inc., brand OXOID, cat # CM 1135B.
Fermentation medium (ph 7.0): 3- (N)Morpholinyl) propanesulfonic acid 21g, urea 5g, ammonium sulfate 5g, dipotassium hydrogen phosphate 1g, potassium dihydrogen phosphate 1g, yeast powder 2g, glucose 40g, magnesium sulfate 0.25g, calcium chloride 0.01g, biotin 0.2mg, trace element solution 1mL, make up to 1L with water. Solution of trace elements: FeSO4·7H2O 16.4g、MnSO4·H2O 100mg、CuSO4200mg、ZnSO4·7H2O 1g、NiCl2·6H2O20 mg, made up to 1L with water.
Example 1 construction of recombinant plasmid and recombinant bacterium
Construction of recombinant plasmid
1. Construction of recombinant plasmid pXMJ19-pro-ssp-dnaB155M-MTG。
Recombinant plasmid pXMJ19-pro-ssp-dnaB155MMTG is circular plasmid and is shown as sequence 1 in the sequence table.
In the sequence 1 of the sequence table, the nucleotide 6304-6322 constitutes the T7 promoter, the nucleotide 6323-6347 constitutes the lac operator, the nucleotide 6350-6385 constitutes the RBS, and the nucleotide 6386-8002 constitutes the complete open reading frame (encoding fusion protein). In the sequence 1 of the sequence table, the 6386-6388 th site is an initiation codon, the 6389-6523 th nucleotide codes a pro region, the 6524-6985 th nucleotide codes an ssp-dnaB intein, the 6986-6986 th nucleotide codes an amino acid residue M, the 6986-7981 th nucleotide codes a mature MTG, and the 7982-7999 th nucleotide codes a His6The tag, nucleotide 8000-8002 is a stop codon.
The fusion protein is shown as a sequence 2 in a sequence table. In the sequence 2 of the sequence table, the 47 th-200 th amino acid residues form ssp-dnaB intein, the 201 th amino acid residue is M, the 202 nd-532 th amino acid residue forms mature MTG, and the 533 nd-538 th amino acid residue forms His6And (4) a label.
Due to the existence of the ssp-dnaB intein, the fusion protein is self-sheared (the shearing site is between the 200 th amino acid residue and the 201 th amino acid residue of the sequence 2), and MTG-His shown in the sequence 3 of the sequence table is obtained6A protein.
2. A recombinant plasmid pXMJ19-pro-MTG was constructed.
And the recombinant plasmid pXMJ19-pro-ssp-dnaB155MThe recombinant plasmid pXMJ19-pro-MTG differs from MTG only in the absence of the part encoding the ssp-dnaB intein (i.e.the absence of nucleotides 6524-6985 in sequence 1 of the sequence Listing).
3. Construction of recombinant plasmid pXMJ19-pro-ssp-dnaB155K-MTG。
And the recombinant plasmid pXMJ19-pro-ssp-dnaB155MRecombinant plasmid pXMJ19-pro-ssp-dnaB compared to MTG155KThe MTG only differs in that the nucleotide at position 6984-6989 in sequence 2 of the sequence listing is mutated from "ATG" to "AAG".
Second, construction of Corynebacterium glutamicum C.glutamicum T7
1. The pK18mobsacB plasmid was digested with the restriction enzyme BamHI, and the linearized plasmid and the T7 homologous recombinant fragment were ligated using the Gibson Assembly kit (NEB), and the resulting recombinant plasmid was named recombinant plasmid pK 18-T7.
The T7 homologous recombination fragment is a double-stranded DNA molecule shown in sequence 4 of the sequence table. In the sequence 4 of the sequence table, the 17 th-502 th nucleotides form an upstream homology arm, the 537 th-4951 th nucleotides form T7-Plac, and the 4955 th-5461 th nucleotides form a downstream homology arm.
2. The recombinant plasmid pK18-T7 is electrically transformed into Corynebacterium glutamicum ATCC13032 (under the electric shock condition: voltage 2.5KV, resistance 200 omega and capacitance 25 muF), recombinant bacteria are obtained through two-time screening (single-exchange recombinant bacteria are obtained through the first screening on a BHI plate containing 25mg/L kanamycin, then the single-exchange recombinant bacteria are cultured in a liquid BHI culture medium overnight, and then homologous recombination double-exchange strains are obtained through the second screening on a BHI plate containing 200g/L sucrose), namely the Corynebacterium glutamicum C.glutamicum T7.
3. And carrying out sequencing verification.
The difference between corynebacterium glutamicum c.glutamicum T7 compared to corynebacterium glutamicum ATCC13032 was only: the double-stranded DNA molecule shown in the sequence 5 in the sequence table in the genomic DNA of Corynebacterium glutamicum ATCC13032 was replaced by a double-stranded DNA molecule shown in the 17 th to 5461 th nucleotides of the sequence table in the sequence table. The genomic DNA of Corynebacterium glutamicum ATCC13032 is shown in GenBank: NC-003450.
Thirdly, constructing recombinant bacteria
The recombinant plasmid pXMJ19-pro-ssp-dnaB155MIntroducing MTG into Corynebacterium glutamicum C.glutamicum T7 to obtain recombinant strain named as CG-pXMJ19-pro-ssp-dnaB155M-MTG。
The recombinant plasmid pXMJ19-pro-MTG is introduced into Corynebacterium glutamicum C.glutamicum T7 to obtain a recombinant strain named as strain CG-pXMJ 19-pro-MTG.
The recombinant plasmid pXMJ19-pro-ssp-dnaB155KIntroducing MTG into Corynebacterium glutamicum C.glutamicum T7 to obtain recombinant strain named as CG-pXMJ19-pro-ssp-dnaB155K-MTG。
Example 2 Shake flask fermentation of recombinant bacteria
First, strain CG-pXMJ19-pro-ssp-dnaB155M-induced fermentation culture of MTG
1. The strain CG-pXMJ19-pro-ssp-dnaB155MAnd (3) inoculating the MTG single colony to a test tube filled with 5mL of liquid BHI culture medium containing 17 mu g/mL of chloramphenicol, and carrying out shake culture at 30 ℃ at 200r/min for 12h to obtain the seed solution.
2. Inoculating 1mL of the seed solution into a 250mL conical flask containing 50mL of a fermentation medium containing 17. mu.g/mL of chloramphenicol, and culturing at 30 ℃ under shaking at 200r/min to OD600nmThe value is 1.
3. After completing step 2, IPTG was added to the culture system to a concentration of 0.5mM in the system, followed by shaking culture at 25 ℃ and 200r/min for 48 hours, at which time the OD of the system was600nmThe value was about 20, and the system was named as a fermentation product.
4. Taking fermentation product (with bacterial load: OD)600nm Value x volume 20; the volume unit is ml), centrifuging for 5min at 12000r/min, and collecting thalli sediment; the cell pellet was resuspended in 1mL Tris-HCl buffer (pH8.0, 50mM), then sonicated (sonication parameters: 200W, 5s stop for 5s, total time 20min), after sonication, the sample was taken as a whole bacterial solution, and the remainder of the sample was centrifuged (10000 Xg, 5min) to collect the supernatant.
II, strain CG-pXMJ19-pro-ssp-dnaB155MNon-induced fermentative culture of MTG
And (5) adding no IPTG, and performing the same step one.
Thirdly, induced fermentation culture of the strain CG-pXMJ19-pro-MTG
Replacement of the strain CG-pXMJ19-pro-ssp-dnaB with the strain CG-pXMJ19-pro-MTG155MMTG, other same steps one.
Fourthly, strain CG-pXMJ19-pro-ssp-dnaB155K-induced fermentation culture of MTG
With the strain CG-pXMJ19-pro-ssp-dnaB155KMTG replacement for the strain CG-pXMJ19-pro-ssp-dnaB155MMTG, other same steps one.
Protein electrophoresis
And (4) taking the whole bacteria liquid and the supernatant obtained in the step one, the whole bacteria liquid and the supernatant obtained in the step two, and the whole bacteria liquid and the supernatant obtained in the step three, and performing SDS-PAGE.
The electrophoretogram is shown in FIG. 1. In fig. 1: lane 1: the whole fungus liquid obtained in the step two; lane 2: the supernatant obtained in the step two; lane 3: the whole fungus liquid obtained in the third step; lane 4: the supernatant obtained in the third step; lane 5: the whole fungus liquid obtained in the step one; lane 6: supernatant obtained in the first step; lane M: and (3) protein marker.
The results show that: strain CG-pXMJ19-pro-ssp-dnaB without IPTG induction155M-MTG is unable to produce the protein of interest; in the absence of ssp-dnaB155MIn the case of (i.e.strain CG-pXMJ19-pro-MTG), mature MTG could not be produced.
Sixth, method for detecting MTG enzyme activity
MTG enzyme activity definition: the amount of enzyme required to catalyze the formation of 1. mu. mol of L-glutamic acid-. gamma. -monohydroxyhydroxamic acid at 37 ℃ per minute was defined as 1U.
MTG enzyme activity determination method (colorimetric method): taking 200 mu L of a sample to be detected after preheating at 37 ℃ or a diluent of the sample to be detected (if no special description is provided, a solvent adopted for dilution is Tris-HCl buffer solution with pH6.0 and 0.2mol/L), adding 500 mu L of a substrate solution after preheating at 37 ℃, reacting for 10min at 37 ℃, then adding 200 mu L of a terminator, centrifuging for 5min at 10000 Xg, collecting supernatant, and measuring a light absorption value at the wavelength of 525 nm; preparing standard solutions with different concentrations by using L-glutamic acid-gamma-monohydroxyhydroxamic acid as a solute and water as a solvent, measuring light absorption values at the wavelength of 525nm respectively, and making a standard curve equation (in the standard curve equation, x is the concentration of the L-glutamic acid-gamma-monohydroxyhydroxamic acid, and y is the light absorption value); substituting the light absorption value obtained in the step one into the standard curve equation obtained in the step two, and calculating to obtain the MTG enzyme activity of the sample to be detected.
The preparation method of the substrate solution comprises the following steps: 100mg of N-CBZ-Gln-Gly was dissolved in 2mL of 0.2mol/L NaOH aqueous solution, and then 4mL of Tris-HCl buffer (pH6.0, 0.2mol/L), 2mL of 0.1mol/L hydroxylamine aqueous solution and 2mL of 0.01mol/L reduced glutathione aqueous solution were added to adjust the pH to 6.0.
A terminating agent: containing 1mol/L HCl, 4g/100ml trichloroacetic acid, 5g/100ml FeCl3·6H2O and the balance of water.
Seventhly, detecting MTG enzyme activity
And taking the supernatant obtained in the step one, the supernatant obtained in the step three and the supernatant obtained in the step four as samples to be detected respectively, detecting the MTG enzyme activity, and calculating to obtain the enzyme activity of the fermentation product.
The enzyme activity of the fermentation product obtained in the first step is 14U/mL.
And the enzyme activity of the fermentation product obtained in the third step is 0U/mL.
The enzyme activity of the fermentation product obtained in the fourth step is 0.2U/mL.
The enzyme activities of the fermentation product obtained in the first step and the fermentation product obtained in the fourth step are compared and shown in FIG. 2.
Eighth, preparation of MTG-His6Solution and sequencing identification and detection of enzyme activity
1. Collecting the supernatant obtained in step one, filtering with 0.22 μm filter membrane, performing nickel column affinity chromatography, and collecting the solution containing target protein (MTG-His)6Protein).
2. Taking the post-column solution obtained in the step 1, desalting by adopting a column type ultrafiltration membrane with the aperture of 3KD and a Tris-HCl buffer solution with the pH value of 8.0 and 50mM to obtain a protein solution with the Tris-HCl buffer solution with the pH value of 8.0 and 50mM as a solvent system, and naming the protein solution as MTG-His6And (3) solution.
3. Performing N-terminal sequencing
Taking the MTG-His obtained in the step 26The solution was subjected to 12.5% SDS-PAGE, which was transferred onto a PVDF membrane, and the transfer effect was examined by ponceau staining. Sending to the protein sequencing laboratory of the life center of Beijing university, and determining that the 5 amino acid sequences at the N-terminal are M-D-S-D-D by an Edman method. As a result, the strain CG-pXMJ19-pro-ssp-dnaB was found155MThe MTG expresses the fusion protein in cells, and the fusion protein is self-sheared (the shearing site is between the 200 th amino acid residue and the 201 th amino acid residue of the sequence 2) due to the existence of the ssp-dnaB intein to obtain the MTG-His shown in the sequence 3 of the sequence table6A protein. The above steps can obtain active MTG-His without secondary treatment6A protein.
4. Detection of MTG enzyme Activity
Taking the MTG-His obtained in the step 26And (3) taking the solution as a sample to be detected, and detecting the MTG enzyme activity.
Taking the MTG-His obtained in the step 26And (4) detecting the protein concentration by using a Bradford method.
MTG-His6Enzyme activity of the solution was divided by MTG-His6Protein concentration of the solution to obtain MTG-His6The specific activity of the protein is 33U/mg.
EXAMPLE 3 fermenter culture of recombinant bacteria
1. Preparation of seed liquid
The strain CG-pXMJ19-pro-ssp-dnaB155MAnd (3) inoculating the MTG single colony to a test tube filled with 5mL of liquid BHI culture medium containing 17 mu g/mL of chloramphenicol, and carrying out shake culture at 30 ℃ at 200r/min for 12h to obtain the seed solution. Multiple tubes were used to prepare multiple seed solutions.
2. 100mL of the seed solution was inoculated into a 2.5L fermentor containing 1L of a fermentation medium containing 17. mu.g/mL chloramphenicol and fermented for 48 hours. During the fermentation process, the temperature is controlled at 25 ℃, and the pH value is controlled at about 7.0 by feeding ammonia water. During the fermentation process, when the system OD600nmWhen the value reached 8-10, IPTG was added to make the concentration in the system 0.5 mM. During the fermentation, the glucose concentration of the system was monitored and maintained at 4-6g/L by feeding 50g/100ml of an aqueous glucose solution.After fermentation is complete, the system OD600nmThe value was about 70, and the system was named as a fermentation product.
3. Taking fermentation product (with bacterial load: OD)600nm Value x volume 20; the volume unit is ml), centrifuging for 5min at 12000r/min, and collecting thalli sediment; the pellet was resuspended in 1mL Tris-HCl buffer (pH8.0, 50mM), then sonicated (sonication parameters: 200W, 5s stop for 5s for a total time of 20min), and then centrifuged (10000 Xg, 5min) to collect the supernatant.
4. And (4) taking the supernatant obtained in the step (3) as a sample to be detected, detecting the MTG enzyme activity, and calculating to obtain the enzyme activity of the fermentation product.
The enzyme activity of the fermentation product is 49U/mL.
Example 4 study of the enzymatic Properties of MTG
MTG-His6The solution was MTG-His prepared in step eight of example 26And (3) solution.
First, optimum reaction temperature and temperature stability
1. Optimum reaction temperature
Taking MTG-His6And (3) taking the solution as a sample to be detected, and detecting the MTG enzyme activity. The method for detecting MTG enzyme activity refers to step six of example 2. The reaction temperature is set to 30 ℃, 37 ℃, 45 ℃, 50 ℃, 55 ℃ or 60 ℃ respectively.
And taking the highest enzyme activity point as 100% enzyme activity, and calculating the relative enzyme activity at other temperatures. The results are shown in FIG. 3.
The highest point of enzyme activity is used as the optimal reaction temperature. The optimum reaction temperature is 55 ℃.
2. Temperature stability
Taking MTG-His6The solutions are respectively placed at three temperatures (40 ℃, 50 ℃ or 60 ℃), sampled every 20 minutes and used as samples to be detected to detect the MTG enzyme activity.
Taking MTG-His6And (3) taking the solution as a sample to be detected, detecting the MTG enzyme activity and taking the MTG enzyme activity as a reference enzyme activity.
The method for detecting MTG enzyme activity refers to step six of example 2.
The thermal stability curve was plotted with the reference enzyme activity as 100%. The results are shown in FIG. 4. The activity was retained at 40 ℃ for 100 minutes at 90%, at 50 ℃ for 100 minutes at 30% and at 60 ℃ for 20 minutes at substantially lost.
Second, optimum pH and pH stability
The substrate buffers were: 50mM acetate-sodium acetate buffer, pH5.0, 50mM acetate-sodium acetate buffer, pH6.0, 50mM Tris-HCl buffer, pH7.0, 50mM Tris-HCl buffer, pH8.0, 50mM Tris-HCl buffer, pH9.0, 50mM Tris-HCl buffer.
1. Optimum pH
Taking MTG-His6And (3) diluting the solution to 10 times of volume by using a substrate buffer solution, and detecting the MTG enzyme activity as a sample to be detected.
The method for detecting MTG enzyme activity refers to step six of example 2.
The preparation method of the substrate solution comprises the following steps: 100mg of N-CBZ-Gln-Gly was dissolved in 2mL of 0.2mol/L aqueous NaOH solution, and then 4mL of substrate buffer solution, 2mL of 0.1mol/L aqueous hydroxylamine solution and 2mL of 0.01mol/L aqueous reduced glutathione solution were added to adjust the pH to the pH of the substrate buffer solution.
And taking the highest enzyme activity point as 100% enzyme activity, and calculating the relative enzyme activity under other pH values. The results are shown in FIG. 5.
The highest point of enzyme activity is the optimum reaction pH. The optimum reaction pH was 7.0.
2. Stability of pH
Taking MTG-His6And (3) diluting the solution to 10 times of volume by using a substrate buffer solution, standing at room temperature for 1h, and detecting the MTG enzyme activity as a sample to be detected.
Taking MTG-His6And (3) diluting the solution to 10 times of volume by using a Tris-HCl buffer solution with the pH value of 8.0 and the concentration of 50mM, and taking the diluted solution as a sample to be detected to detect the MTG enzyme activity and as a reference enzyme activity.
The method for detecting MTG enzyme activity refers to step six of example 2.
The pH stability curve was plotted with the reference enzyme activity as 100%. The results are shown in FIG. 6. Treating at pH5.0-7.0 for 1 hr, and retaining more than 80% activity; treating at pH8.0-9.0 for 1 hr to retain over 60% activity; 70% activity was lost by treatment at pH4.0 for 1 h.
Influence of metal ions, EDTA and PMSF on enzyme activity
Taking MTG-His6And (3) taking the solution as a sample to be detected, detecting the MTG enzyme activity and taking the MTG enzyme activity as a reference enzyme activity.
Taking MTG-His6Adding an inhibitor into the solution, enabling the concentration of the inhibitor to be 1mM, standing the solution at room temperature for 1h, and taking the solution as a sample to be detected to detect the MTG enzyme activity.
The method for detecting MTG enzyme activity refers to step six of example 2.
The reference enzyme activity was taken as 100%, and the relative enzyme activity after the action of each inhibitor was calculated.
The results are shown in Table 1. Na (Na)+、K+、Ca2+、Mg2+Has no influence on the MTG enzyme activity. Cu2+、Mn2+、Fe2+Has certain inhibition effect on enzyme activity, but still retains more than 70 percent of activity. Zn2+Has strong inhibition effect on MTG activity, and the activity is basically completely lost after treatment. EDTA and PMSF do not produce inhibition effect on enzyme activity.
TABLE 1
Inhibitor contained in test solution Relative enzyme activity (%)
CuSO4 76.19±2.27
MnSO4 77.19±6.85
NaCl 113.46±3.64
KCl 113.67±3.90
CaCl2 108.20±3.46
ZnSO4 1.18±0.17
FeSO4 87.23±1.20
MgSO4 111.07±2.40
EDTA 116.33±6.11
PMSF 113.73±4.96
SEQUENCE LISTING
<110> institute of microbiology of Chinese academy of sciences
<120> method for efficiently producing transglutaminase and special engineering bacteria thereof
<130> GNCYX200805
<160> 5
<170> PatentIn version 3.5
<210> 1
<211> 8186
<212> DNA
<213> Artificial sequence
<400> 1
tagtgtgggg tctccccatg cgagagtagg gaactgccag gcatcaaata aaacgaaagg 60
ctcagtcgaa agactgggcc tttcgtttta tctgttgttt gtcggtgaac gctctcctga 120
gtaggacaaa tccgccggga gcggatttga acgttgcgaa gcaacggccc ggagggtggc 180
gggcaggacg cccgccataa actgccaggc atcaaattaa gcagaaggcc atcctgacgg 240
atggcctttt tgcgtttcta caaactcttt tgtttatttt tctaaataca ttcaaatatg 300
tatccgctca tgagacaata accctgataa atgcttcaat aatattgaaa aaggaagagt 360
atgagtattc aacatttccg tgtcgccctt attccctttt ttgcggcatt ttgccttcct 420
gtttttgctc acccagaaac gctggtgaaa gtaaaagatg ctgaagatca gttgggtgca 480
cgagtgggtt acatcgaact ggatctcaac agcggtaaga tccttgagag ttttcgcccc 540
gaagaacgtt ttccaatgat gagcactttt gcttcctcgc tcactgactc gctgcgctcg 600
gtcgttcggc tgcggcgagc ggtatcagct cactcaaagg cggtaatacg gttatccaca 660
gaatcagggg ataacgcagg aaagaacatg tgagcaaaag gccagcaaaa ggccaggaac 720
cgtaaaaagg ccgcgttgct ggcgtttttc cataggctcc gcccccctga cgagcatcac 780
aaaaatcgac gctcaagtca gaggtggcga aacccgacag gactataaag ataccaggcg 840
tttccccctg gaagctccct cgtgcgctct cctgttccga ccctgccgct taccggatac 900
ctgtccgcct ttctcccttc gggaagcgtg gcgctttctc aatgctcacg ctgtaggtat 960
ctcagttcgg tgtaggtcgt tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag 1020
cccgaccgct gcgccttatc cggtaactat cgtcttgagt ccaacccggt aagacacgac 1080
ttatcgccac tggcagcagc cactggtaac aggattagca gagcgaggta tgtaggcggt 1140
gctacagagt tcttgaagtg gtggcctaac tacggctaca ctagaaggac agtatttggt 1200
atctgcgctc tgctgaagcc agttaccttc ggaaaaagag ttggtagctc ttgatccggc 1260
aaacaaacca ccgctggtag cggtggtttt tttgtttgca agcagcagat tacgcgcaga 1320
aaaaaaggat ctcaagaaga tcctttgatc ttttctacgg ggtctgacgc tcagtggaac 1380
gaaaactcac gttaagggat tttggtcatg agattatcaa aaaggatctt cacctagatc 1440
cttttggggt gggcgaagaa ctccagcatg agatccccgc gctggaggat catccagcca 1500
ttcggggtcg ttcactggtt cccctttctg atttctggca tagaagaacc cccgtgaact 1560
gtgtggttcc gggggttgct gatttttgcg agacttctcg cgcaattccc tagcttaggt 1620
gaaaacacca tgaaacacta gggaaacacc catgaaacac ccattagggc agtagggcgg 1680
cttcttcgtc tagggcttgc atttgggcgg tgatctggtc tttagcgtgt gaaagtgtgt 1740
cgtaggtggc gtgctcaatg cactcgaacg tcacgtcatt taccgggtca cggtgggcaa 1800
agagaactag tgggttagac attgttttcc tcgttgtcgg tggtggtgag cttttctagc 1860
cgctcggtaa acgcggcgat catgaactct tggaggtttt caccgttctg catgcctgcg 1920
cgcttcatgt cctcacgtag tgccaaagga acgcgtgcgg tgaccacgac gggcttagcc 1980
tttgcctgcg cttctagtgc ttcgatggtg gcttgtgcct gcgcttgctg cgcctgtagt 2040
gcctgttgag cttcttgtag ttgctgttct agctgtgcct tggttgccat gctttaagac 2100
tctagtagct ttcctgcgat atgtcatgcg catgcgtagc aaacattgtc ctgcaactca 2160
ttcattatgt gcagtgctcc tgttactagt cgtacatact catatttacc tagtctgcat 2220
gcagtgcatg cacatgcagt catgtcgtgc taatgtgtaa aacatgtaca tgcagattgc 2280
tgggggtgca gggggcggag ccaccctgtc catgcggggt gtggggcttg ccccgccggt 2340
acagacagtg agcaccgggg cacctagtcg cggatacccc ccctaggtat cggacacgta 2400
accctcccat gtcgatgcaa atctttaaca ttgagtacgg gtaagctggc acgcatagcc 2460
aagctaggcg gccaccaaac accactaaaa attaatagtc cctagacaag acaaaccccc 2520
gtgcgagcta ccaactcata tgcacggggg ccacataacc cgaaggggtt tcaattgaca 2580
accatagcac tagctaagac aacgggcaca acacccgcac aaactcgcac tgcgcaaccc 2640
cgcacaacat cgggtctagg taacactgag taacactgaa atagaagtga acacctctaa 2700
ggaaccgcag gtcaatgagg gttctaaggt cactcgcgct agggcgtggc gtaggcaaaa 2760
cgtcatgtac aagatcacca atagtaaggc tctggcgggg tgccataggt ggcgcaggga 2820
cgaagctgtt gcggtgtcct ggtcgtctaa cggtgcttcg cagtttgagg gtctgcaaaa 2880
ctctcactct cgctgggggt cacctctggc tgaattggaa gtcatgggcg aacgccgcat 2940
tgagctggct attgctacta agaatcactt ggcggcgggt ggcgcgctca tgatgtttgt 3000
gggcactgtt cgacacaacc gctcacagtc atttgcgcag gttgaagcgg gtattaagac 3060
tgcgtactct tcgatggtga aaacatctca gtggaagaaa gaacgtgcac ggtacggggt 3120
ggagcacacc tatagtgact atgaggtcac agactcttgg gcgaacggtt ggcacttgca 3180
ccgcaacatg ctgttgttct tggatcgtcc actgtctgac gatgaactca aggcgtttga 3240
ggattccatg ttttcccgct ggtctgctgg tgtggttaag gccggtatgg acgcgccact 3300
gcgtgagcac ggggtcaaac ttgatcaggt gtctacctgg ggtggagacg ctgcgaaaat 3360
ggcaacctac ctcgctaagg gcatgtctca ggaactgact ggctccgcta ctaaaaccgc 3420
gtctaagggg tcgtacacgc cgtttcagat gttggatatg ttggccgatc aaagcgacgc 3480
cggcgaggat atggacgctg ttttggtggc tcggtggcgt gagtatgagg ttggttctaa 3540
aaacctgcgt tcgtcctggt cacgtggggc taagcgtgct ttgggcattg attacataga 3600
cgctgatgta cgtcgtgaaa tggaagaaga actgtacaag ctcgccggtc tggaagcacc 3660
ggaacgggtc gaatcaaccc gcgttgctgt tgctttggtg aagcccgatg attggaaact 3720
gattcagtct gatttcgcgg ttaggcagta cgttctcgat tgcgtggata aggctaagga 3780
cgtggccgct gcgcaacgtg tcgctaatga ggtgctggca agtctgggtg tggattccac 3840
cccgtgcatg atcgttatgg atgatgtgga cttggacgcg gttctgccta ctcatgggga 3900
cgctactaag cgtgatctga atgcggcggt gttcgcgggt aatgagcaga ctattcttcg 3960
cacccactaa aagcggcata aaccccgttc gatattttgt gcgatgaatt tatggtcaat 4020
gtcgcggggg caaactatga tgggtcttgt tgttggcgtc ccggaaaacg attccgaagc 4080
ccaacctttc atagaaggcg gcggtggaat cgaaatctcg tgatggcagg ttgggcgtcg 4140
cttggtcggt catttcgaag ggcaccaata actgccttaa aaaaattacg ccccgccctg 4200
ccactcatcg cagtactgtt gtaattcatt aagcattctg ccgacatgga agccatcaca 4260
gacggcatga tgaacctgaa tcgccagcgg catcagcacc ttgtcgcctt gcgtataata 4320
tttgcccatg gtgaaaacgg gggcgaagaa gttgtccata ttggccacgt ttaaatcaaa 4380
actggtgaaa ctcacccagg gattggctga gacgaaaaac atattctcaa taaacccttt 4440
agggaaatag gccaggtttt caccgtaaca cgccacatct tgcgaatata tgtgtagaaa 4500
ctgccggaaa tcgtcgtggt attcactcca gagcgatgaa aacgtttcag tttgctcatg 4560
gaaaacggtg taacaagggt gaacactatc ccatatcacc agctcaccgt ctttcattgc 4620
catacggaac tccggatgag cattcatcag gcgggcaaga atgtgaataa aggccggata 4680
aaacttgtgc ttatttttct ttacggtctt taaaaaggcc gtaatatcca gctgaacggt 4740
ctggttatag gtacattgag caactgactg aaatgcctca aaatgttctt tacgatgcca 4800
ttgggatata tcaacggtgg tatatccagt gatttttttc tccattttag cttccttagc 4860
tcctgaaaat ctcgtcgaag ctcggcggat ttgtcctact caagctgatc cgacaaaatc 4920
cacacattat cccaggtgtc cggatcggtc aaatacgctg ccagctcata gaccgtatcc 4980
aaagcatccg gggctgatcc ccggcgccag ggtggttttt cttttcacca gtgagacggg 5040
caacagctga ttgcccttca ccgcctggcc ctgagagagt tgcagcaagc ggtccacgtg 5100
gtttgcccca gcaggcgaaa atcctgtttg atggtggtta acggcgggat ataacatgag 5160
ctgtcttcgg tatcgtcgta tcccactacc gagatatccg caccaacgcg cagcccggac 5220
tcggtaatgg cgcgcattgc gcccagcgcc atctgatcgt tggcaaccag catcgcagtg 5280
ggaacgatgc cctcattcag catttgcatg gtttgttgaa aaccggacat ggcactccag 5340
tcgccttccc gttccgctat cggctgaatt tgattgcgag tgagatattt atgccagcca 5400
gccagacgca gacgcgccga gacagaactt aatgggcccg ctaacagcgc gatttgctgg 5460
tgacccaatg cgaccagatg ctccacgccc agtcgcgtac cgtcttcatg ggagaaaata 5520
atactgttga tgggtgtctg gtcagagaca tcaagaaata acgccggaac attagtgcag 5580
gcagcttcca cagcaatggc atcctggtca tccagcggat agttaatgat cagcccactg 5640
acgcgttgcg cgagaagatt gtgcaccgcc gctttacagg cttcgacgcc gcttcgttct 5700
accatcgaca ccaccacgct ggcacccagt tgatcggcgc gagatttaat cgccgcgaca 5760
atttgcgacg gcgcgtgcag ggccagactg gaggtggcaa cgccaatcag caacgactgt 5820
ttgcccgcca gttgttgtgc cacgcggttg ggaatgtaat tcagctccgc catcgccgct 5880
tccacttttt cccgcgtttt cgcagaaacg tggctggcct ggttcaccac gcgggaaacg 5940
gtctgataag agacaccggc atactctgcg acatcgtata acgttactgg tttcacattc 6000
accaccctga attgactctc ttccgggcgc tatcatgcca taccgcgaaa ggttttgcac 6060
cattcgatgg tgtcaacgta aatgccgctt cgccttcgcg cgcgaattgc aagctgatcc 6120
gggcttatcg actgcacggt gcaccaatgc ttctggcgtc cgctcatgag cccgaagtgg 6180
cgagcccgat cttccccatc ggtgatgtcg gcgatatagg cgccagcaac cgcacctgtg 6240
gcgccggtga tgccggccac gatgcgtccg gcgtagagga tcgagatctc gatcccgcga 6300
aattaatacg actcactata ggggaattgt gagcggataa caattcccca ataattttgt 6360
ttaactttaa gaaggagata tacatatgga caatggcgcg ggggaagaga cgaagtccta 6420
cgccgaaacc taccgcctca cggcggatga cgtcgcgaac atcaacgcgc tcaacgaaag 6480
cgctccggcc gcttcgagcg ccggcccgtc gttccgggcc cccgctatct ctggcgatag 6540
tctgatcagc ctggctagca caggaaaaag agtttctatt aaagatttgt tagatgaaaa 6600
agattttgaa atatgggcaa ttaatgaaca gacgatgaag ctagaatcag ctaaagttag 6660
tcgtgtattt tgtactggca aaaagctagt ttatattcta aaaactcgac taggtagaac 6720
tatcaaggca acagcaaatc atagattttt aactattgat ggttggaaaa gattagatga 6780
gctatcttta aaagagcata ttgctctacc ccgtaaacta gaaagctcct ctttacaatt 6840
gtcaccagaa atagaaaagt tgtctcagag tgatatttac tgggactcca tcgtttctat 6900
tacggagact ggagtcgaag aggtttttga tttgactgtg ccaggaccac ataactttgt 6960
cgcgaatgac atcattgtac acaacatgga ctccgacgac agggtcaccc ctcccgccga 7020
gccgctcgac aggatgcccg acccgtaccg tccctcgtac ggcagggccg agacggtcgt 7080
caacaactac atacgcaagt ggcagcaggt ctacagccac cgcgacggca ggaagcagca 7140
gatgaccgag gagcagcggg agtggctgtc ctacggctgc gtcggtgtca cctgggtcaa 7200
ttcgggtcag tacccgacga acagactggc cttcgcgtcc ttcgacgagg acaggttcaa 7260
gaacgagctg aagaacggca ggccccggtc cggcgagacg cgggcggagt tcgagggccg 7320
cgtcgcgaag gagagcttcg acgaggagaa gggcttccag cgggcgcgtg aggtggcgtc 7380
cgtcatgaac agggccctgg agaacgccca cgacgagagc gcttacctcg acaacctcaa 7440
gaaggaactg gcgaacggca acgacgccct gcgcaacgag gacgcccgtt ccccgttcta 7500
ctcggcgctg cggaacacgc cgtccttcaa ggagcggaac ggaggcaatc acgacccgtc 7560
caggatgaag gccgtcatct actcgaagca cttctggagc ggccaggacc ggtcgagttc 7620
ggccgacaag aggaagtacg gcgacccgga cgccttccgc cccgccccgg gcaccggcct 7680
ggtcgacatg tcgagggaca ggaacattcc gcgcagcccc accagccccg gtgagggatt 7740
cgtcaatttc gactacggct ggttcggcgc ccagacggaa gcggacgccg acaagaccgt 7800
ctggacccac ggaaatcact atcacgcgcc caatggcagc ctgggtgcca tgcatgtcta 7860
cgagagcaag ttccgcaact ggtccgaggg ttactcggac ttcgaccgcg gagcctatgt 7920
gatcaccttc atccccaaga gctggaacac cgcccccgac aaggtaaagc agggctggcc 7980
gcaccaccac caccaccact gaccgggtac cgagctcgaa ttcagcttgg ctgttttggc 8040
ggatgagaga agattttcag cctgatacag attaaatcag aacgcagaag cggtctgata 8100
aaacagaatt tgcctggcgg cagtagcgcg gtggtcccac ctgaccccat gccgaactca 8160
gaagtgaaac gccgtagcgc cgatgg 8186
<210> 2
<211> 538
<212> PRT
<213> Artificial sequence
<400> 2
Met Asp Asn Gly Ala Gly Glu Glu Thr Lys Ser Tyr Ala Glu Thr Tyr
1 5 10 15
Arg Leu Thr Ala Asp Asp Val Ala Asn Ile Asn Ala Leu Asn Glu Ser
20 25 30
Ala Pro Ala Ala Ser Ser Ala Gly Pro Ser Phe Arg Ala Pro Ala Ile
35 40 45
Ser Gly Asp Ser Leu Ile Ser Leu Ala Ser Thr Gly Lys Arg Val Ser
50 55 60
Ile Lys Asp Leu Leu Asp Glu Lys Asp Phe Glu Ile Trp Ala Ile Asn
65 70 75 80
Glu Gln Thr Met Lys Leu Glu Ser Ala Lys Val Ser Arg Val Phe Cys
85 90 95
Thr Gly Lys Lys Leu Val Tyr Ile Leu Lys Thr Arg Leu Gly Arg Thr
100 105 110
Ile Lys Ala Thr Ala Asn His Arg Phe Leu Thr Ile Asp Gly Trp Lys
115 120 125
Arg Leu Asp Glu Leu Ser Leu Lys Glu His Ile Ala Leu Pro Arg Lys
130 135 140
Leu Glu Ser Ser Ser Leu Gln Leu Ser Pro Glu Ile Glu Lys Leu Ser
145 150 155 160
Gln Ser Asp Ile Tyr Trp Asp Ser Ile Val Ser Ile Thr Glu Thr Gly
165 170 175
Val Glu Glu Val Phe Asp Leu Thr Val Pro Gly Pro His Asn Phe Val
180 185 190
Ala Asn Asp Ile Ile Val His Asn Met Asp Ser Asp Asp Arg Val Thr
195 200 205
Pro Pro Ala Glu Pro Leu Asp Arg Met Pro Asp Pro Tyr Arg Pro Ser
210 215 220
Tyr Gly Arg Ala Glu Thr Val Val Asn Asn Tyr Ile Arg Lys Trp Gln
225 230 235 240
Gln Val Tyr Ser His Arg Asp Gly Arg Lys Gln Gln Met Thr Glu Glu
245 250 255
Gln Arg Glu Trp Leu Ser Tyr Gly Cys Val Gly Val Thr Trp Val Asn
260 265 270
Ser Gly Gln Tyr Pro Thr Asn Arg Leu Ala Phe Ala Ser Phe Asp Glu
275 280 285
Asp Arg Phe Lys Asn Glu Leu Lys Asn Gly Arg Pro Arg Ser Gly Glu
290 295 300
Thr Arg Ala Glu Phe Glu Gly Arg Val Ala Lys Glu Ser Phe Asp Glu
305 310 315 320
Glu Lys Gly Phe Gln Arg Ala Arg Glu Val Ala Ser Val Met Asn Arg
325 330 335
Ala Leu Glu Asn Ala His Asp Glu Ser Ala Tyr Leu Asp Asn Leu Lys
340 345 350
Lys Glu Leu Ala Asn Gly Asn Asp Ala Leu Arg Asn Glu Asp Ala Arg
355 360 365
Ser Pro Phe Tyr Ser Ala Leu Arg Asn Thr Pro Ser Phe Lys Glu Arg
370 375 380
Asn Gly Gly Asn His Asp Pro Ser Arg Met Lys Ala Val Ile Tyr Ser
385 390 395 400
Lys His Phe Trp Ser Gly Gln Asp Arg Ser Ser Ser Ala Asp Lys Arg
405 410 415
Lys Tyr Gly Asp Pro Asp Ala Phe Arg Pro Ala Pro Gly Thr Gly Leu
420 425 430
Val Asp Met Ser Arg Asp Arg Asn Ile Pro Arg Ser Pro Thr Ser Pro
435 440 445
Gly Glu Gly Phe Val Asn Phe Asp Tyr Gly Trp Phe Gly Ala Gln Thr
450 455 460
Glu Ala Asp Ala Asp Lys Thr Val Trp Thr His Gly Asn His Tyr His
465 470 475 480
Ala Pro Asn Gly Ser Leu Gly Ala Met His Val Tyr Glu Ser Lys Phe
485 490 495
Arg Asn Trp Ser Glu Gly Tyr Ser Asp Phe Asp Arg Gly Ala Tyr Val
500 505 510
Ile Thr Phe Ile Pro Lys Ser Trp Asn Thr Ala Pro Asp Lys Val Lys
515 520 525
Gln Gly Trp Pro His His His His His His
530 535
<210> 3
<211> 338
<212> PRT
<213> Artificial sequence
<400> 3
Met Asp Ser Asp Asp Arg Val Thr Pro Pro Ala Glu Pro Leu Asp Arg
1 5 10 15
Met Pro Asp Pro Tyr Arg Pro Ser Tyr Gly Arg Ala Glu Thr Val Val
20 25 30
Asn Asn Tyr Ile Arg Lys Trp Gln Gln Val Tyr Ser His Arg Asp Gly
35 40 45
Arg Lys Gln Gln Met Thr Glu Glu Gln Arg Glu Trp Leu Ser Tyr Gly
50 55 60
Cys Val Gly Val Thr Trp Val Asn Ser Gly Gln Tyr Pro Thr Asn Arg
65 70 75 80
Leu Ala Phe Ala Ser Phe Asp Glu Asp Arg Phe Lys Asn Glu Leu Lys
85 90 95
Asn Gly Arg Pro Arg Ser Gly Glu Thr Arg Ala Glu Phe Glu Gly Arg
100 105 110
Val Ala Lys Glu Ser Phe Asp Glu Glu Lys Gly Phe Gln Arg Ala Arg
115 120 125
Glu Val Ala Ser Val Met Asn Arg Ala Leu Glu Asn Ala His Asp Glu
130 135 140
Ser Ala Tyr Leu Asp Asn Leu Lys Lys Glu Leu Ala Asn Gly Asn Asp
145 150 155 160
Ala Leu Arg Asn Glu Asp Ala Arg Ser Pro Phe Tyr Ser Ala Leu Arg
165 170 175
Asn Thr Pro Ser Phe Lys Glu Arg Asn Gly Gly Asn His Asp Pro Ser
180 185 190
Arg Met Lys Ala Val Ile Tyr Ser Lys His Phe Trp Ser Gly Gln Asp
195 200 205
Arg Ser Ser Ser Ala Asp Lys Arg Lys Tyr Gly Asp Pro Asp Ala Phe
210 215 220
Arg Pro Ala Pro Gly Thr Gly Leu Val Asp Met Ser Arg Asp Arg Asn
225 230 235 240
Ile Pro Arg Ser Pro Thr Ser Pro Gly Glu Gly Phe Val Asn Phe Asp
245 250 255
Tyr Gly Trp Phe Gly Ala Gln Thr Glu Ala Asp Ala Asp Lys Thr Val
260 265 270
Trp Thr His Gly Asn His Tyr His Ala Pro Asn Gly Ser Leu Gly Ala
275 280 285
Met His Val Tyr Glu Ser Lys Phe Arg Asn Trp Ser Glu Gly Tyr Ser
290 295 300
Asp Phe Asp Arg Gly Ala Tyr Val Ile Thr Phe Ile Pro Lys Ser Trp
305 310 315 320
Asn Thr Ala Pro Asp Lys Val Lys Gln Gly Trp Pro His His His His
325 330 335
His His
<210> 4
<211> 5482
<212> DNA
<213> Artificial sequence
<400> 4
gagctcggta cccgggacaa ctctttcacg taagttcttc gtttctgcta ccacagccct 60
ggcggcagtc gcactggttg cgtgttcccc taatgagatt gattctgaac tgaaggtgcc 120
aacggcaact ggcgtttctt taccttcgaa gaacgtttcc gcgacctcaa ctgctactac 180
agatgaggat gcgcctggct acattgattg cgtagccgca ccaactcagc aacctgctga 240
aatctcacta aactgtgcaa tggatattga tcggctcacg gatatttctt ggagcgaatg 300
ggatactgat tccgcaactg gaaccggtac ccgcatcgta accgctgcaa atggtcaaga 360
gaccgaaacc gaagatattg aggtgaagct ttccttcccc accgagtctt cccaaggcct 420
agtgttcact caggtcaccg tcgatggaca ggttctcttc ctctaatcct ccataattag 480
agagcgtaag gcccctactt ccgcaactcg tgaaaggtag gcggatccag atcccggaca 540
ccatcgaatg gcgcaaaacc tttcgcggta tggcatgata gcgcccggaa gagagtcaat 600
tcagggtggt gaatgtgaaa ccagtaacgt tatacgatgt cgcagagtat gccggtgtct 660
cttatcagac cgtttcccgc gtggtgaacc aggccagcca cgtttctgcg aaaacgcggg 720
aaaaagtgga agcggcgatg gcggagctga attacattcc caaccgcgtg gcacaacaac 780
tggcgggcaa acagtcgttg ctgattggcg ttgccacctc cagtctggcc ctgcacgcgc 840
cgtcgcaaat tgtcgcggcg attaaatctc gcgccgatca actgggtgcc agcgtggtgg 900
tgtcgatggt agaacgaagc ggcgtcgaag cctgtaaagc ggcggtgcac aatcttctcg 960
cgcaacgcgt cagtgggctg atcattaact atccgctgga tgaccaggat gccattgctg 1020
tggaagctgc ctgcactaat gttccggcgt tatttcttga tgtctctgac cagacaccca 1080
tcaacagtat tattttctcc catgaagacg gtacgcgact gggcgtggag catctggtcg 1140
cattgggtca ccagcaaatc gcgctgttag cgggcccatt aagttctgtc tcggcgcgtc 1200
tgcgtctggc tggctggcat aaatatctca ctcgcaatca aattcagccg atagcggaac 1260
gggaaggcga ctggagtgcc atgtccggtt ttcaacaaac catgcaaatg ctgaatgagg 1320
gcatcgttcc cactgcgatg ctggttgcca acgatcagat ggcgctgggc gcaatgcgcg 1380
ccattaccga gtccgggctg cgcgttggtg cggatatctc ggtagtggga tacgacgata 1440
ccgaagacag ctcatgttat atcccgccgt taaccaccat caaacaggat tttcgcctgc 1500
tggggcaaac cagcgtggac cgcttgctgc aactctctca gggccaggcg gtgaagggca 1560
atcagctgtt gcccgtctca ctggtgaaaa gaaaaaccac cctggcgccc aatacgcaaa 1620
ccgcctctcc ccgcgcgttg gccgattcat taatgcagct ggcacgacag gtttcccgac 1680
tggaaagcgg gcagtgagcg caacgcaatt aatgtaagtt agctcactca ttaggcaccc 1740
caggctttac actttatgct tccggctcgt ataatgtgtg gaattgtgag cggataacaa 1800
tttcacacag gaaacagcta tgaccatgat tacggattca ctggccgtcg ttttacaacg 1860
tcgtgactgg gaaaaccctg gcgttaccca acttaatcgc cttgcagcac atcccccttt 1920
cgccagctgg cgtaatagcg aagaggcccg caccgatcgc ccttcccaac agttgcgcag 1980
cctgaatggc gaatggcgct ttgcctggtt tccggcacca gaagcggtgc cggaaagctg 2040
gctggagtgc gatcttcctg aggccgatac tgtcgtcgtc ccctcaaact ggcagatgca 2100
cggttacgat gcgcccatct acaccaacgt gacctatccc attacggtca atccgccgtt 2160
tgttcccacg gagaatccga cgggttgtta ctcgctcaca tttaatgttg atgaaagctg 2220
gctacaggaa ggccagacgc gaattatttt tgatggcgtc gggatctgat ccggatttac 2280
taactggaag aggcactaaa tgaacacgat taacatcgct aagaacgact tctctgacat 2340
cgaactggct gctatcccgt tcaacactct ggctgaccat tacggtgagc gtttagctcg 2400
cgaacagttg gcccttgagc atgagtctta cgagatgggt gaagcacgct tccgcaagat 2460
gtttgagcgt caacttaaag ctggtgaggt tgcggataac gctgccgcca agcctctcat 2520
cactacccta ctccctaaga tgattgcacg catcaacgac tggtttgagg aagtgaaagc 2580
taagcgcggc aagcgcccga cagccttcca gttcctgcaa gaaatcaagc cggaagccgt 2640
agcgtacatc accattaaga ccactctggc ttgcctaacc agtgctgaca atacaaccgt 2700
tcaggctgta gcaagcgcaa tcggtcgggc cattgaggac gaggctcgct tcggtcgtat 2760
ccgtgacctt gaagctaagc acttcaagaa aaacgttgag gaacaactca acaagcgcgt 2820
agggcacgtc tacaagaaag catttatgca agttgtcgag gctgacatgc tctctaaggg 2880
tctactcggt ggcgaggcgt ggtcttcgtg gcataaggaa gactctattc atgtaggagt 2940
acgctgcatc gagatgctca ttgagtcaac cggaatggtt agcttacacc gccaaaatgc 3000
tggcgtagta ggtcaagact ctgagactat cgaactcgca cctgaatacg ctgaggctat 3060
cgcaacccgt gcaggtgcgc tggctggcat ctctccgatg ttccaacctt gcgtagttcc 3120
tcctaagccg tggactggca ttactggtgg tggctattgg gctaacggtc gtcgtcctct 3180
ggcgctggtg cgtactcaca gtaagaaagc actgatgcgc tacgaagacg tttacatgcc 3240
tgaggtgtac aaagcgatta acattgcgca aaacaccgca tggaaaatca acaagaaagt 3300
cctagcggtc gccaacgtaa tcaccaagtg gaagcattgt ccggtcgagg acatccctgc 3360
gattgagcgt gaagaactcc cgatgaaacc ggaagacatc gacatgaatc ctgaggctct 3420
caccgcgtgg aaacgtgctg ccgctgctgt gtaccgcaag gacaaggctc gcaagtctcg 3480
ccgtatcagc cttgagttca tgcttgagca agccaataag tttgctaacc ataaggccat 3540
ctggttccct tacaacatgg actggcgcgg tcgtgtttac gctgtgtcaa tgttcaaccc 3600
gcaaggtaac gatatgacca aaggactgct tacgctggcg aaaggtaaac caatcggtaa 3660
ggaaggttac tactggctga aaatccacgg tgcaaactgt gcgggtgtcg ataaggttcc 3720
gttccctgag cgcatcaagt tcattgagga aaaccacgag aacatcatgg cttgcgctaa 3780
gtctccactg gagaacactt ggtgggctga gcaagattct ccgttctgct tccttgcgtt 3840
ctgctttgag tacgctgggg tacagcacca cggcctgagc tataactgct cccttccgct 3900
ggcgtttgac gggtcttgct ctggcatcca gcacttctcc gcgatgctcc gagatgaggt 3960
aggtggtcgc gcggttaact tgcttcctag tgaaaccgtt caggacatct acgggattgt 4020
tgctaagaaa gtcaacgaga ttctacaagc agacgcaatc aatgggaccg ataacgaagt 4080
agttaccgtg accgatgaga acactggtga aatctctgag aaagtcaagc tgggcactaa 4140
ggcactggct ggtcaatggc tggcttacgg tgttactcgc agtgtgacta agcgttcagt 4200
catgacgctg gcttacgggt ccaaagagtt cggcttccgt caacaagtgc tggaagatac 4260
cattcagcca gctattgatt ccggcaaggg tctgatgttc actcagccga atcaggctgc 4320
tggatacatg gctaagctga tttgggaatc tgtgagcgtg acggtggtag ctgcggttga 4380
agcaatgaac tggcttaagt ctgctgctaa gctgctggct gctgaggtca aagataagaa 4440
gactggagag attcttcgca agcgttgcgc tgtgcattgg gtaactcctg atggtttccc 4500
tgtgtggcag gaatacaaga agcctattca gacgcgcttg aacctgatgt tcctcggtca 4560
gttccgctta cagcctacca ttaacaccaa caaagatagc gagattgatg cacacaaaca 4620
ggagtctggt atcgctccta actttgtaca cagccaagac ggtagccacc ttcgtaagac 4680
tgtagtgtgg gcacacgaga agtacggaat cgaatctttt gcactgattc acgactcctt 4740
cggtaccatt ccggctgacg ctgcgaacct gttcaaagca gtgcgcgaaa ctatggttga 4800
cacatatgag tcttgtgatg tactggctga tttctacgac cagttcgctg accagttgca 4860
cgagtctcaa ttggacaaaa tgccagcact tccggctaaa ggtaacttga acctccgtga 4920
catcttagag tcggacttcg cgttcgcgta acgcggaaat aggggccttt tgttgtcttc 4980
tcctggaggc tatttaagaa gtttaaattg tgtccatgag ttcgcgtatg gcaatgacag 5040
tttgagacgg ccacaggcga ttctgagaag ccattttctt tgggcgccgt ggcagttttt 5100
attgggtccc accgccgaac tgcatattcg aaccaaggag cctcaaaaat cgagctcgct 5160
ttggtctcaa acgcacattt atcgcgcgtt gaagtgtgcg tttgagacca aagagccctc 5220
cacaacgcac gtctttggtt tggatatgac aggtgcccaa gaactcaccc cgccccatgc 5280
tcacagagcc cccatcagaa gccaaaagac cccttccctg cccaagaaga acaggatgaa 5340
ggggtcttgt gctgcgtaaa ctagcggttt tggaagtagc taagcagacg taggatttcg 5400
gtgtagagcc agaccaaggt cactgcaaga ccaagcgcaa cgccccatgc catcttggaa 5460
gggaaatagg ggccttttgt tg 5482
<210> 5
<211> 1000
<212> DNA
<213> Artificial sequence
<400> 5
acaactcttt cacgtaagtt cttcgtttct gctaccacag ccctggcggc agtcgcactg 60
gttgcgtgtt cccctaatga gattgattct gaactgaagg tgccaacggc aactggcgtt 120
tctttacctt cgaagaacgt ttccgcgacc tcaactgcta ctacagatga ggatgcgcct 180
ggctacattg attgcgtagc cgcaccaact cagcaacctg ctgaaatctc actaaactgt 240
gcaatggata ttgatcggct cacggatatt tcttggagcg aatgggatac tgattccgca 300
actggaaccg gtacccgcat cgtaaccgct gcaaatggtc aagagaccga aaccgaagat 360
attgaggtga agctttcctt ccccaccgag tcttcccaag gcctagtgtt cactcaggtc 420
accgtcgatg gacaggttct cttcctctaa tcctccataa ttagagagcg taaggcccct 480
acttcctgtt ttaggaaata ggggcctttt gttgtcttct cctggaggct atttaagaag 540
tttaaattgt gtccatgagt tcgcgtatgg caatgacagt ttgagacggc cacaggcgat 600
tctgagaagc cattttcttt gggcgccgtg gcagttttta ttgggtccca ccgccgaact 660
gcatattcga accaaggagc ctcaaaaatc gagctcgctt tggtctcaaa cgcacattta 720
tcgcgcgttg aagtgtgcgt ttgagaccaa agagccctcc acaacgcacg tctttggttt 780
ggatatgaca ggtgcccaag aactcacccc gccccatgct cacagagccc ccatcagaag 840
ccaaaagacc ccttccctgc ccaagaagaa caggatgaag gggtcttgtg ctgcgtaaac 900
tagcggtttt ggaagtagct aagcagacgt aggatttcgg tgtagagcca gaccaaggtc 960
actgcaagac caagcgcaac gccccatgcc atcttggaag 1000

Claims (10)

1. A protein which is (a1) or (a2) as follows:
(a1) protein shown by 1-532 th amino acid residues in a sequence 2 in a sequence table;
(a2) a protein shown in a sequence 2 in a sequence table.
2. The protein consists of the following components from N end to C end in sequence: the pro region of MTG, the ssp-dnaB intein, the mature region of amino acid residue M, MTG.
3. The protein comprises the following segments from N end to C end in sequence: the protein or protein tag of claim 2.
4. A nucleic acid molecule encoding the protein of claim 1 or 2 or 3.
5. A DNA molecule encoding the protein of claim 1 or 2 or 3.
6. An expression cassette, recombinant vector or recombinant microorganism having the DNA molecule of claim 5.
7. The recombinant vector of claim 6, wherein: the recombinant vector is (c1) or (c2) as follows:
(c1) a recombinant vector with 6304-8002 nucleotides of sequence 1 in the sequence table;
(c2) the recombinant vector is shown as a sequence 1 in a sequence table.
8. The recombinant microorganism of claim 6, wherein: the recombinant microorganism is obtained by introducing the recombinant vector according to claim 7 into Corynebacterium glutamicum.
9. Use of a protein according to any one of claims 1 to 3, or a nucleic acid molecule according to claim 4, or a DNA molecule according to claim 5, or an expression cassette according to claim 6, or a recombinant vector according to claim 6 or 7, or a recombinant microorganism according to claim 6 or 8 for the preparation of a transglutaminase.
10. A method of preparing transglutaminase comprising the steps of: culturing the recombinant microorganism of claim 8.
CN202010284432.5A 2020-04-13 2020-04-13 Method for efficiently producing transglutaminase and special engineering bacteria thereof Active CN113528478B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010284432.5A CN113528478B (en) 2020-04-13 2020-04-13 Method for efficiently producing transglutaminase and special engineering bacteria thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010284432.5A CN113528478B (en) 2020-04-13 2020-04-13 Method for efficiently producing transglutaminase and special engineering bacteria thereof

Publications (2)

Publication Number Publication Date
CN113528478A true CN113528478A (en) 2021-10-22
CN113528478B CN113528478B (en) 2023-01-20

Family

ID=78087865

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010284432.5A Active CN113528478B (en) 2020-04-13 2020-04-13 Method for efficiently producing transglutaminase and special engineering bacteria thereof

Country Status (1)

Country Link
CN (1) CN113528478B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1759180A (en) * 2003-03-07 2006-04-12 味之素株式会社 Process for producing microbial transglutaminase
WO2007106582A2 (en) * 2006-03-15 2007-09-20 Promethean Lifesciences, Inc. Preparation and storage of stable, biologically active materials
CN108103041A (en) * 2018-02-02 2018-06-01 泰兴市东圣生物科技有限公司 A kind of thermostabilization microbial transglutaminase and its encoding gene

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1759180A (en) * 2003-03-07 2006-04-12 味之素株式会社 Process for producing microbial transglutaminase
WO2007106582A2 (en) * 2006-03-15 2007-09-20 Promethean Lifesciences, Inc. Preparation and storage of stable, biologically active materials
CN108103041A (en) * 2018-02-02 2018-06-01 泰兴市东圣生物科技有限公司 A kind of thermostabilization microbial transglutaminase and its encoding gene

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DU KUN: "pH-dependent activation of Streptomyces hygroscopicus transglutaminase mediated by intein", 《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》 *
FU LIHONG: "Extracellular production of active-form Streptomyces mobaraensis transglutaminase in Bacillus subtilis", 《APPLIED MICROBIOLOGY AND BIOTECHNOLOGY》 *
杜坤等: "内含肽介导谷氨酰胺转胺酶酶原的活化", 《食品科学》 *

Also Published As

Publication number Publication date
CN113528478B (en) 2023-01-20

Similar Documents

Publication Publication Date Title
CN113528479B (en) Efficient preparation method of transglutaminase and special engineering bacteria thereof
CN108486146B (en) Application of LbCpf1-RR mutant in CRISPR/Cpf1 system in plant gene editing
KR101782666B1 (en) METHOD FOR THE PRODUCTION OF L-ORNITHINE USING BACTERIA THAT OVEREXPRESS LysE
JP2002513550A (en) Optimization of pest resistance genes using DNA shuffling
CN108997484B (en) Application of wheat TaWox5 gene in improving wheat transformation efficiency
EA009287B1 (en) Microbial production of l-ascorbic acid
KR20190117806A (en) Plants with Increased Photorespiration Efficiency
CN109022285B (en) Method for improving tolerance capacity of Synechocystis PCC6803 ammonium salt and application thereof
EP1921145A1 (en) RICE BLAST DISEASE GENE Pi21, RESISTANCE GENE pi21 AND UTILIZATION THEREOF
CN113528478B (en) Method for efficiently producing transglutaminase and special engineering bacteria thereof
CN108531502A (en) The structure and inoculation method of citrus decline virus infectious clone
CN111154764A (en) Method for improving disease resistance of rice through genome editing and sgRNA used in method
CN113528561B (en) Recombinant microorganism and method for producing 1, 5-pentanediamine
CN114672509B (en) Corynebacterium and escherichia coli dual-expression vector with high expression capacity and construction method thereof
JP2011103864A (en) Gene encoding protein having deoxynivalenol and nivalenol decomposing activity
CN116286889A (en) Tetrahydrofolic acid dependent dicamba demethylase gene dmt06 and application thereof
CN115011539A (en) Recombinant escherichia coli, preparation method and application thereof, and method for degrading plastics
CN110669794B (en) Cell enrichment technology of C.T base substitution by using mutant screening agent resistance gene as report system and application thereof
CN110938650B (en) mRNA variable shearing-luciferase report system and application thereof
KR102170566B1 (en) Vector for premature termination of target gene expression and strain containing the same
CN116745423A (en) Heterologous peptide production based on fluorescent fusion
CN112626104A (en) Method for producing plectasin by using pichia pastoris
CN113166771A (en) Gene therapy DNA vector GDTT1.8NAS12 and method for obtaining the same
CN110066817A (en) Kelp α type carbonic anhydrase gene Sj α-CA2 and its coding albumen and application
KR20200009010A (en) Organic compound manufacturing method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant